- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Health Bulletin 29/January/2024 - Video
Overview
Here are the top health news for the day:
Three drug treatment regime to be introduced to stop leprosy transmission by 2027
The Union Health Ministry has decided to implement a new treatment regimen for leprosy aimed at stopping its transmission at the sub-national level by 2027, three years ahead of the Sustainable Development Goals. The Ministry of Health has decided to introduce a three-drug regimen for Pauci-Bacillary (PB) cases in place of a two-drug regimen for six months, according to the latest globally accepted scientific research studies and evidence-based practices.
For the full story, check out the link given below:
Centre To Introduce Three Drug Treatment Regime To Stop Leprosy Transmission By 2027
CDSCO Panel gives a green signal to Biological E to study vaccines for 6- 8 weeks old infants
Reviewing the Phase I clinical trial report, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the vaccine maker Biological E to conduct a Phase II clinical trial of Diphtheria, Tetanus, Pertussis (Whole cell), Hepatitis B (rDNA), inactivated Poliomyelitis and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed) for 6- 8 weeks-old infants.
This came after the vaccine maker Biological E presented its proposal for the conduct of a Phase II clinical trial in 6- 8 weeks-old infants along with a Phase I clinical trial report.
For the full story, check out the link given below:
Biological E Gets CDSCO Panel Nod To Study Vaccine For 6- 8 Weeks Old Infants
A 2 kg preterm baby suffering from TGA saved in a 7-hour surgery
In probably one of the first in the private healthcare sector in the Uttar Pradesh, a two kg pre-term baby was born to a young couple and diagnosed to have a condition called TGA (Transposition of Great Arteries).
The baby was put on prostaglandin, a lifesaving medicine and transferred to Tender Palm Hospital in Lucknow, under the care of Dr Vijay Agarwal, senior surgeon.
The child underwent a seven hour-long and difficult surgery by Dr Vijay Agarwal and his team and after keeping the chest open for 24 hours and with a lot of hard work by ICU nursing staff and expert intensivist and paediatrician, he was successfully removed from the ventilator after three days.
For the full story, check out the link given below:
Doctors At UP Hospital Saves 2 Kg Preterm Baby Suffering From TGA In 7 Hour Surgery
Haryana Surgeon slapped Rs 8 lakh compensation for performing Open Surgery instead of Laparoscopic Surgery
The National Consumer Disputes Redressal Commission (NCDRC) recently directed a Haryana-based doctor to pay Rs 8 lakh compensation to the family of a patient, who died after undergoing surgery for swelling in the intestine.
The NCDRC bench upheld the State Commission's order after noting that doctor performed open surgery even though he had informed the relatives that a laparoscopic surgery would be conducted. Consequently, the surgery led to Septicaemia and after fighting for her life for more than a month, the patient died.
For the full story, check out the link given below:
Open Surgery Instead Of Laparoscopic Surgery: Haryana Surgeon Slapped Rs 8 Lakh Compensation